http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4971795-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9217fdade858bfb104397009736dfb02
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-001169
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-705
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-646
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-05
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-48
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-705
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-17
filingDate 1988-07-21-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 1990-11-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4b13a11dd4f953a7ad7ceedaa8e68569
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_38105e4174217740fcb129eb71c0d462
publicationDate 1990-11-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber US-4971795-A
titleOfInvention Enhancement of the cellular immune response using carbohydrate primed DTH effector cells expressing the CD5+/CD8- phenotype
abstract DTH-Effector cells are primed with carbohydrate antigens and used to enhance the cellular immune response. Tumors have been inhibited by DTH-Effector cells primed with epiglycanin and with synthetic T and Tn antigens. Either the DTH-Effector cells, or these tumor-associated carbohydrate antigens directly, may be used for tumor prophylaxis and therapy.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0466813-A4
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-RE38046-E
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2003134341-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5686103-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5798090-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2003039650-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6326009-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2002191021-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0466813-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2003175272-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6582697-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2003134415-A1
priorityDate 1986-07-08-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/GB-2106935-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4690915-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4180627-A
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID439357
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226410539
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID94270
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID136160036
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3034656
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226408335
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226408336
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6713579
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226410540
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226410541
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3037556

Total number of triples: 47.